Martin Infeld Email

EVP Business Development Contract Services . Kashiv Pharma

,

Location

LinkedIn

Current Roles

Employees:
336
Revenue:
$67.5M
About
Kashiv scientists maintain two key focus points. The first is developing and applying novel technologies to improve the delivery of compounds with otherwise problematic physical and/or chemical properties. The Kashiv portfolio of proprietary drug delivery technologies is designed to improve the efficacy, safety, compliance, and dosage of low-bioavailability drugs where absorption could be limited due to solubility, permeability, and/or stability problems. The second area of focus is developing the next generation of improved, abuse-deterrent formulations (ADF) in the hopes of curbing prescription drug abuse. The comprehensive Kashiv ADF platforms target popularly abused drugs, such as opioids, and build in features to prevent common methods of abuse, misuse, and overdose of drugs.
Kashiv Pharma Address
995 US Highway 202/206
null, null
Unknown
Kashiv Pharma Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.